Immunohistochemical distinction of paragangliomas from epithelial neuroendocrine tumors—gangliocytic duodenal and cauda equina paragangliomas align with epithelial neuroendocrine tumors
- 12 July 2020
- journal article
- research article
- Published by Elsevier in Human Pathology
- Vol. 103, 72-82
Abstract
No abstract availableKeywords
Funding Information
- National Institutes of Health
This publication has 30 references indexed in Scilit:
- A Study of Gata3 and Phox2b Expression in Tumors of the Autonomic Nervous SystemAmerican Journal of Surgical Pathology, 2013
- A Simple Method for Generating Multitissue Blocks Without Special EquipmentApplied Immunohistochemistry & Molecular Morphology, 2012
- Hormonally defined pancreatic and duodenal neuroendocrine tumors differ in their transcription factor signatures: expression of ISL1, PDX1, NGN3, and CDX2Virchows Archiv, 2011
- Sox10‐positive sustentacular cells in neuroendocrine carcinoma of the lungHistopathology, 2011
- Gata3 participates in a complex transcriptional feedback network to regulate sympathoadrenal differentiationDevelopment, 2006
- Catecholamine-Synthesizing Enzymes in Carcinoid Tumors and PheochromocytomasClinical Chemistry, 2003
- Paragangliomas of the cauda equina have a distinctive cytokeratin immunophenotypeHistopathology, 1992
- Immunocytochemistry of paragangliomas—value of staining for S‐100 protein and glial fibrillary acid protein in diagnosis and prognosisHistopathology, 1991
- Transient coexpression of desmin and cytokeratins 8 and 18 in developing myocardial cells of some vertebrate speciesDifferentiation, 1988
- Monoclonal Antibody Studies of Mammalian Epithelial Keratins: A Review aAnnals of the New York Academy of Sciences, 1985